CAI
HealthcareCaris Life Sciences Inc - Class A
$19.13+0.18 (+0.95%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CAI Today?
No stock-specific AI insight has been generated for CAI yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$5.4B
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume1.7M
Avg Volume (10D)—
Shares Outstanding282.7M
CAI News
20 articles- Assessing Caris Life Sciences (CAI) Valuation As Shares Trade Below Narrative Fair ValueYahoo Finance·May 9, 2026
- Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing AuthorizationYahoo Finance·May 8, 2026
- Caris (CAI) Q1 2026 Earnings Call TranscriptMotley Fool·May 7, 2026
- Caris Life Sciences Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- Caris Life Sciences Reports First Quarter 2026 Financial ResultsYahoo Finance·May 7, 2026
- Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of DiagnosisYahoo Finance·May 5, 2026
- Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid MalignanciesYahoo Finance·May 4, 2026
- Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma PatientsYahoo Finance·Apr 29, 2026
- 3 Stocks Estimated To Be Trading Up To 43% Below Intrinsic ValueYahoo Finance·Apr 28, 2026
- Ligand Pharmaceuticals And 2 Other Stocks That May Be Trading At An Estimated DiscountYahoo Finance·Apr 28, 2026
- Caris Life Sciences, Inc. (CAI) Coverage Begins at Neutral as Piper Cites Need for Growth AccelerationYahoo Finance·Apr 24, 2026
- Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare ConferenceYahoo Finance·Apr 24, 2026
- Jefferies Initiates Coverage of Caris Life Sciences Inc. (CAI) With a Buy RatingYahoo Finance·Apr 20, 2026
- Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026Yahoo Finance·Apr 20, 2026
- Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer CenterYahoo Finance·Apr 17, 2026
- Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer PatientsYahoo Finance·Apr 15, 2026
- April 2026's Estimated Undervalued Stocks For Savvy InvestorsYahoo Finance·Apr 15, 2026
- Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC PatientsYahoo Finance·Apr 8, 2026
- 3 Stocks Estimated To Be Undervalued In April 2026Yahoo Finance·Apr 8, 2026
- Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid MalignanciesYahoo Finance·Apr 2, 2026
All 20 articles loaded
Price Data
Open$19.23
Previous Close$18.95
Day High$19.27
Day Low$18.14
52 Week High—
52 Week Low—
Fundamentals
Market Cap$5.4B
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume1.7M
Avg Volume (10D)—
Shares Outstanding282.7M
About Caris Life Sciences Inc - Class A
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
HealthcareSERVICES-MEDICAL LABORATORIES
Company Details
Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SICSERVICES-MEDICAL LABORATORIES
CIK—
Composite FIGI—
Share Class FIGI—